Mays Cancer Center led studies of innovative breast cancer drug that recently gained FDA approval
February 1, 2023
The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for postmenopausal women and adult men with ER+/HER2- advanced …
Texas Public Radio, The Source: For foster youth often left behind, a new $4 million health care grant gives hope
February 1, 2023
Karen Walker Schwab, PhD, APRN, CPNP-PC, associate professor/clinical, pediatric nurse practitioner and director of Pediatric Services at the UT Health San Antonio School of Nursing, was interviewed on The Source program. Listen Now
Mays Cancer Center led studies of innovative breast cancer drug that recently gained FDA approval
February 1, 2023
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO (Feb. 1, 2023) — The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for ela …
Vote today and every day until Feb. 15 to secure YourSA Readers’ Choice awards for UT Health San Antonio
February 1, 2023
Help UT Health San Antonio secure two spots in the San Antonio Express-News Readers’ Choice awards. The institution has advanced to the YourSA Readers’ Choice voting round in the “Medical Practice Group” and “Dentist” categories.
Staff Emergency Fund available to help employees with financial hardship
January 31, 2023
When a UT Health San Antonio employee faces a temporary financial hardship caused by an emergency or non-emergent situation, the UT Health San Antonio Staff Emergency Fund may help. “Anyone can encounter challenging financial times with changing circum …
Alzheimer’s disease clinical trial seeks 21 area volunteers
January 31, 2023
Study will evaluate senolytics — drugs that clear defective ‘zombie’ cells A clinical trial conducted at UT Health San Antonio aims to “stomp” out Alzheimer’s disease. Clearing old, damaged “zombie” cells from the brain may be one way to do it. The stu …
Register Now for the 2023 LINC IPE Symposium
January 30, 2023
Continuing to bring award-winning interprofessional education (IPE) opportunities to UT Health San Antonio faculty, staff and students, Linking Interprofessional Networks for Collaboration, or LINC, is hosting its second annual LINC IPE Symposiu …
Alzheimer’s disease clinical trial seeks 21 area volunteers
January 30, 2023
Study will evaluate senolytics — drugs that clear defective ‘zombie’ cells Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Jan. 30, 2023) — A clinical trial conducted at UT Health San Antonio aims to “stomp” out Alzheimer’s disease. …
Cure: First Patient Injected With Novel Radiotherapy in Phase 2b Trial for Brain Cancer
January 30, 2023
Andrew Brenner, MD, PhD, neuro-oncologist who treats patients at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, and professor of medicine, was quoted in this article. Read More
KSAT 12: Robb Elementary survivor Mayah Zamora reunited with lifesaving blood donors
January 30, 2023
Ronald M. Stewart, MD, trauma specialist and chair, Department of Surgery, was quoted in this news segment. Read More